Cash on hand has been the question.
It looks as though revenue will meet expenditure next qr. I do question expenditure estimates for next qr but it looks as though NZ Cannabis and Crystal Mountain Hydro will cover it. If we spend $2.5 mill, THC will still eat into cash. The ace in the hand is the stabilisation testing for MC product in Australia for Australian patients. Those sales are THC becoming revenue and cash burn even and then easing into profit, IMO.
The joker in the pack is worldwide export into some of the 29 countries we are certified to export to.
I can see THC getting through to positive cash flow without the need to raise capital from here. Fit out is complete at Southport. Crops are being grown. Cost of import cannabis is very cheap. Sales announcements and offtakes are very close according to company announcements.
What is your sentiment here?
Cash on hand has been the question.It looks as though revenue...
-
- There are more pages in this discussion • 37 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add EPN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $7.208M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| EPN (ASX) Chart |
Day chart unavailable